UMIN ID: UMIN000002122
Registered date:26/06/2009
An exploratory study of administration of colistin for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease. |
| Date of first enrollment | 2009/06/01 |
| Target sample size | 5 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Colistin is administered intravenously. The dosage is 1.25-2.5mg/kg twice a day. The treetment period is between 3 and 28 days. |
Outcome(s)
| Primary Outcome | A clinical response at the end of colistin therapy |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. Allergy for colistin 2. A woman who is pregnant or has chance to be pregnant. |
Related Information
| Primary Sponsor | University of Tokyo Hospital Department of Hamatology and Oncology |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Fumihiko Nakamura |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan Japan |
| Telephone | 03-3815-5411 |
| fnakamur-tky@umin.ac.jp | |
| Affiliation | University of Tokyo Hospital Hematology and Oncology |
| scientific contact | |
| Name | Fumihiko Nakamura |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan Japan |
| Telephone | 03-3815-5411 |
| fnakamur-tky@umin.ac.jp | |
| Affiliation | University of Tokyo Hospital hematology and Oncology |